The clinical impact of serrated colorectal polyps

Clinical Epidemiology

Volumn 9, Issue , 2017, Pages 113-125

  O’Connell, Brendon M ^a   Crockett, Seth D ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Colonoscopy; Epidemiology; Hyperplastic polyp; Serrated polyp; Sessile serrated adenoma; Sessile serrated polyp; Traditional serrated adenoma

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

AFRICAN AMERICAN; AGE DISTRIBUTION; APOPTOSIS; BRAF GENE; CARCINOGENESIS; CAUCASIAN; CELL PROLIFERATION; CLINICAL FEATURE; COLONOSCOPY; COLORECTAL POLYP; COMPUTED TOMOGRAPHY ENTEROGRAPHY; DIETARY INTAKE; DISEASE CLASSIFICATION; DISEASE SURVEILLANCE; DOWN REGULATION; EPIDEMIOLOGICAL MONITORING; EPIGENETICS; GENE MUTATION; GENE SILENCING; HISPANIC; HUMAN; MALIGNANT TRANSFORMATION; MOLECULAR DYNAMICS; ONCOGENE; PHYSICAL ACTIVITY; RACE DIFFERENCE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SERRATED COLORECTAL POLYP; SEX DIFFERENCE; SIGMOIDOSCOPY; TAXONOMY; WORLD HEALTH ORGANIZATION;

EID: 85015776768     PISSN: None     EISSN: 11791349     Source Type: Journal    
DOI: 10.2147/CLEP.S106257     Document Type: Review

References (133)

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7–30.
2. Snover DC. Update on the serrated pathway to colorectal carcinoma. Hum Pathol. 2011;42(1):1–10.
3. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61(5):759–767.
4. Leggett B, Whitehall V. Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology. 2010;138(6):2088–2100.
5. Sawhney MS, Farrar WD, Gudiseva S, et al. Microsatellite instability in interval colon cancers. Gastroenterology. 2006;131(6):1700–1705.
6. Cooper HS, Patchefsky AS, Marks G. Adenomatous and carcinomatous changes within hyperplastic colonic epithelium. Dis Colon Rectum. 1979;22(3):152–156.
7. Jass JR. Relation between metaplastic polyp and carcinoma of the colorectum. Lancet Lond Engl. 1983;1(8314–8315):28–30.
8. Longacre TA, Fenoglio-Preiser CM. Mixed hyperplastic adenomatous polyps/serrated adenomas. A distinct form of colorectal neoplasia. Am J Surg Pathol. 1990;14(6):524–537.
9. Torlakovic EE, Gomez JD, Driman DK, et al. Sessile serrated adenoma (SSA) vs. traditional serrated adenoma (TSA). Am J Surg Pathol. 2008;32(1):21–29.
10. Snover D, Ahnen DJ, Burt RW, et al. Serrated polyps of the colon and rectum and serrated (“hyperplastic”) polyposis. In: Bozman FT TN Carneiro F, Hruban RH, editors. WHO Classification of Tumours Pathology and Genetics Tumours of the Digestive System. 4th edn. Berlin, Germany: Springer-Verlag; 2010.
11. Huang CS, O’brien MJ, Yang S, Farraye FA. Hyperplastic polyps, serrated adenomas, and the serrated polyp neoplasia pathway. Am J Gastroenterol. 2004;99(11):2242–2255.
12. Waye JD, Bilotta JJ. Rectal hyperplastic polyps: now you see them, now you don’t – a differential point. Am J Gastroenterol. 1990;85(12): 1557–1559.
13. Torlakovic E, Skovlund E, Snover DC, Torlakovic G, Nesland JM. Morphologic reappraisal of serrated colorectal polyps. Am J Surg Pathol. 2003;27(1):65–81.
14. East JE, Saunders BP, Jass JR. Sporadic and syndromic hyperplastic polyps and serrated adenomas of the colon: classification, molecular genetics, natural history, and clinical management. Gastroenterol Clin North Am. 2008;37(1):25–46.
15. Lash RH, Genta RM, Schuler CM. Sessile serrated adenomas: prevalence of dysplasia and carcinoma in 2139 patients. J Clin Pathol. 2010;63(8):681–686.
16. Goldstein NS, Bhanot P, Odish E, Hunter S. Hyperplastic-like colon polyps that preceded microsatellite-unstable adenocarcinomas. Am J Clin Pathol. 2003;119(6):778–796.
17. Hetzel JT, Huang CS, Coukos JA, et al. Variation in the detection of serrated polyps in an average risk colorectal cancer screening cohort. Am J Gastroenterol. 2010;105(12):2656–2664.
18. Lambert R, Kudo SE, Vieth M, et al. Pragmatic classification of superficial neoplastic colorectal lesions. Gastrointest Endosc. 2009; 70(6):1182–1199.
19. Jaramillo E, Tamura S, Mitomi H. Endoscopic appearance of serrated adenomas in the colon. Endoscopy. 2005;37(3):254–260.
20. Rex DK, Ahnen DJ, Baron JA, et al. Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol. 2012;107(9):1315–1329.
21. Yantiss RK, Oh KY, Chen YT, Redston M, Odze RD. Filiform serrated adenomas: a clinicopathologic and immunophenotypic study of 18 cases. Am J Surg Pathol. 2007;31(8):1238–1245.
22. Kim KM, Lee EJ, Kim YH, Chang DK, Odze RD. KRAS mutations in traditional serrated adenomas from Korea herald an aggressive phenotype. Am J Surg Pathol. 2010;34(5):667–675.
23. Li SC, Burgart L. Histopathology of serrated adenoma, its variants, and differentiation from conventional adenomatous and hyperplastic polyps. Arch Pathol Lab Med. 2007;131(3):440–445.
24. Morita T, Tamura S, Miyazaki J, Higashidani Y, Onishi S. Evaluation of endoscopic and histopathological features of serrated adenoma of the colon. Endoscopy. 2001;33(9):761–765.
25. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988;319(9):525–532.
26. Garnett MJ, Marais R. Guilty as charged: B-RAF is a human oncogene. Cancer Cell. 2004;6(4):313–319.
27. Samowitz WS, Albertsen H, Herrick J, et al. Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology. 2005;129(3):837–845.
28. Hawkins N, Norrie M, Cheong K, et al. CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability. Gastroenterology. 2002;122(5):1376–1387.
29. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A. 1999;96(15):8681–8686.
30. Kane MF, Loda M, Gaida GM, et al. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res. 1997;57(5):808–811.
31. Weisenberger DJ, Siegmund KD, Campan M, et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet. 2006;38(7):787–793.
32. O’Brien MJ, Yang S, Mack C, et al. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am J Surg Pathol. 2006;30(12):1491–1501.
33. Spring KJ, Zhao ZZ, Karamatic R, et al. High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology. 2006;131(5):1400–1407.
34. O’Brien MJ. Hyperplastic and serrated polyps of the colorectum. Gastroenterol Clin North Am. 2007;36(4):947–968.
35. Yang S, Farraye FA, Mack C, Posnik O, O’Brien MJ. BRAF and KRAS mutations in hyperplastic polyps and serrated adenomas of the colorectum: relationship to histology and CpG island methylation status. Am J Surg Pathol. 2004;28(11):1452–1459.
36. Fu B, Yachida S, Morgan R, Zhong Y, Montgomery EA, Iacobuzio-Donahue CA. Clinicopathologic and genetic characterization of traditional serrated adenomas of the colon. Am J Clin Pathol. 2012;138(3):356–366.
37. Bos JL. Ras oncogenes in human cancer: a review. Cancer Res. 1989; 49(17):4682–4689.
38. Yamashita N, Minamoto T, Ochiai A, Onda M, Esumi H. Frequent and characteristic K-ras activation in aberrant crypt foci of colon. Is there preference among K-ras mutants for malignant progression? Cancer. 1995;75(Suppl 6):1527–1533.
39. Whitehall VL, Walsh MD, Young J, Leggett BA, Jass JR. Methylation of O-6-methylguanine DNA methyltransferase characterizes a subset of colorectal cancer with low-level DNA microsatellite instability. Cancer Res. 2001;61(3):827–830.
40. Tsai J, Liau J, Lin Y, et al. Traditional serrated adenoma has two pathways of neoplastic progression that are distinct from the sessile serrated pathway of colorectal carcinogenesis. Mod Pathol. 2014; 27(10):1375–1385.
41. Guarinos C, Sanchez-Fortun C, Rodriguez-Soler M, Alenda C, Paya A, Jover R. Serrated polyposis syndrome: molecular, pathological and clinical aspects. World J Gastroenterol. 2012;18(20):2452–2461.
42. Rubio CA, Stemme S, Jaramillo E, Lindblom A. Hyperplastic polyposis coli syndrome and colorectal carcinoma. Endoscopy. 2006; 38(3):266–270.
43. Leggett BA, Devereaux B, Biden K, Searle J, Young J, Jass J. Hyperplastic polyposis: association with colorectal cancer. Am J Surg Pathol. 2001;25(2):177–184.
44. Buchanan DD, Sweet K, Drini M, et al. Phenotypic diversity in patients with multiple serrated polyps: a genetics clinic study. Int J Colorectal Dis. 2010;25(6):703–712.
45. Boparai KS, Reitsma JB, Lemmens V, et al. Increased colorectal cancer risk in first-degree relatives of patients with hyperplastic polyposis syndrome. Gut. 2010;59(9):1222–1225.
46. Young J, Jass JR. The case for a genetic predisposition to serrated neoplasia in the colorectum: hypothesis and review of the literature. Cancer Epidemiol Biomark Prev. 2006;15(10):1778–1784.
47. Young J, Jenkins M, Parry S, et al. Serrated pathway colorectal cancer in the population: genetic consideration. Gut. 2007;56(10):1453–1459.
48. Syngal S, Brand RE, Church JM, Giardiello FM, Hampel HL, Burt RW. ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol. 2015; 110(2):223.
49. Williams AR, Balasooriya BA, Day DW. Polyps and cancer of the large bowel: a necropsy study in Liverpool. Gut. 1982;23(10):835–842.
50. Higuchi T, Sugihara K, Jass JR. Demographic and pathological characteristics of serrated polyps of colorectum. Histopathology 2005; 47(1):32–40.
51. Carr NJ, Mahajan H, Tan KL, Hawkins NJ, Ward RL. Serrated and non-serrated polyps of the colorectum: their prevalence in an unselected case series and correlation of BRAF mutation analysis with the diagnosis of sessile serrated adenoma. J Clin Pathol. 2009;62(6): 516–518.
52. Buda A, Bona MD, Dotti I, et al. Prevalence of different subtypes of serrated polyps and risk of synchronous advanced colorectal neoplasia in average-risk population undergoing first-time colonoscopy. Clin Transl Gastroenterol. 2012;3:e6.
53. Kahi CJ, Li X, Eckert GJ, Rex DK. High colonoscopic prevalence of proximal colon serrated polyps in average-risk men and women. Gastrointest Endosc. 2012;75(3):515–520.
54. Lieberman DA, Prindiville S, Weiss DG, Willett W, 380 VCSG. Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals. Jama. 2003;290(22):2959–2967.
55. Martinez ME, McPherson RS, Levin B, Glober GA. A case-control study of dietary intake and other lifestyle risk factors for hyperplastic polyps. Gastroenterology. 1997;113(2):423–429.
56. Ji BT, Weissfeld JL, Chow WH, Huang WY, Schoen RE, Hayes RB. Tobacco smoking and colorectal hyperplastic and adenomatous polyps. Cancer Epidemiol Biomark Prev. 2006;15(5):897–901.
57. Kearney J, Giovannucci E, Rimm EB, et al. Diet, alcohol, and smoking and the occurrence of hyperplastic polyps of the colon and rectum (United States). Cancer Causes Control CCC. 1995;6(1):45–56.
58. Morimoto LM, Newcomb PA, Ulrich CM, Bostick RM, Lais CJ, Potter JD. Risk factors for hyperplastic and adenomatous polyps: evidence for malignant potential? Cancer Epidemiol Biomark Prev. 2002; 11(10 Pt 1):1012–1018.
59. Burnett-Hartman AN, Passarelli MN, Adams SV, et al. Differences in epidemiologic risk factors for colorectal adenomas and serrated polyps by lesion severity and anatomical site. Am J Epidemiol. 2013; 177(7):625–637.
60. Omata F, Brown WR, Tokuda Y, et al. Modifiable risk factors for colorectal neoplasms and hyperplastic polyps. Intern Med Tokyo Jpn. 2009;48(3):123–128.
61. Bailie L, Loughrey MB, Coleman HG. Lifestyle risk factors for serrated colorectal polyps: a systematic review and meta-analysis. Gastroenterology. 2017;152(1):92–104.
62. Wallace K, Grau MV, Ahnen D, et al. The association of lifestyle and dietary factors with the risk for serrated polyps of the colorectum. Cancer Epidemiol Biomark Prev. 2009;18(8):2310–2317.
63. Anderson JC, Rangasamy P, Rustagi T, et al. Risk factors for sessile serrated adenomas. J Clin Gastroenterol. 2011;45(8):694–699.
64. Davenport JR, Su T, Zhao Z, et al. Modifiable lifestyle factors associated with risk of sessile serrated polyps, conventional adenomas and hyperplastic polyps. Gut. 2016; pii: gutjnl-2016-312893. [Epub ahead of print].
65. Sheridan TB, Fenton H, Lewin MR, et al. Sessile serrated adenomas with low- and high-grade dysplasia and early carcinomas: an immunohistochemical study of serrated lesions “caught in the act.” Am J Clin Pathol. 2006;126(4):564–571.
66. Patil DT, Shadrach BL, Rybicki LA, Leach BH, Pai RK. Proximal colon cancers and the serrated pathway: a systematic analysis of precursor histology and BRAF mutation status. Mod Pathol. 2012;25(10): 1423–1431.
67. Makinen MJ, George SM, Jernvall P, Makela J, Vihko P, Karttunen TJ. Colorectal carcinoma associated with serrated adenoma – prevalence, histological features, and prognosis. J Pathol. 2001;193(3):286–294.
68. Garcia-Solano J, Perez-Guillermo M, Conesa-Zamora P, et al. Clinicopathologic study of 85 colorectal serrated adenocarcinomas: further insights into the full recognition of a new subset of colorectal carcinoma. Hum Pathol. 2010;41(10):1359–1368.
69. Matsumoto T, Mizuno M, Shimizu M, Manabe T, Iida M. Clinicopathological features of serrated adenoma of the colorectum: comparison with traditional adenoma. J Clin Pathol. 1999;52(7):513–516.
70. Jaramillo E, Watanabe M, Befrits R, de Leon EP, Rubio C, Slezak P. Small, flat colorectal neoplasias in long-standing ulcerative colitis detected by high-resolution electronic video endoscopy. Gastrointest Endosc. 1996;44(1):15–22.
71. Rubio CA, Jaramillo E. Flat serrated adenomas of the colorectal mucosa. Jpn J Cancer Res Gann. 1996;87(3):305–309.
72. Song SY, Kim YH, Yu MK, et al. Comparison of malignant potential between serrated adenomas and traditional adenomas. J Gastroenterol Hepatol. 2007;22(11):1786–1790.
73. Chino A, Yamamoto N, Kato Y, et al. The frequency of early colorectal cancer derived from sessile serrated adenoma/polyps among 1858 serrated polyps from a single institution. Int J Colorectal Dis. 2016;31(2):343–349.
74. Huang CS, Farraye FA, Yang S, O’Brien MJ. The clinical significance of serrated polyps. Am J Gastroenterol. 2011;106(2):229–240.
75. Goldstein NS. Small colonic microsatellite unstable adenocarcinomas and high-grade epithelial dysplasias in sessile serrated adenoma polypectomy specimens: a study of eight cases. Am J Clin Pathol. 2006;125(1):132–145.
76. Jass JR. Serrated route to colorectal cancer: back street or super highway? J Pathol. 2001;193(3):283–285.
77. Oono Y, Fu K, Nakamura H, et al. Progression of a sessile serrated adenoma to an early invasive cancer within 8 months. Dig Dis Sci. 2009; 54(4):906–909.
78. Nakamura H, Fu K, Parra-Blanco A, et al. A sessile colonic polyp showing striking morphological changes within a 2-month period. Endoscopy. 2007;(39 Suppl 1):E279–E80.
79. Li D, Jin C, McCulloch C, et al. Association of large serrated polyps with synchronous advanced colorectal neoplasia. Am J Gastroenterol. 2009;104(3):695–702.
80. Schreiner MA, Weiss DG, Lieberman DA. Proximal and large hyperplastic and nondysplastic serrated polyps detected by colonoscopy are associated with neoplasia. Gastroenterology. 2010;139(5):1497–1502.
81. Hiraoka S, Kato J, Fujiki S, et al. The presence of large serrated polyps increases risk for colorectal cancer. Gastroenterology. 2010;139(5): 1503–1510.
82. Hazewinkel Y, de Wijkerslooth TR, Stoop EM, et al. Prevalence of serrated polyps and association with synchronous advanced neoplasia in screening colonoscopy. Endoscopy. 2014;46(3):219–224.
83. Ng SC, Ching JYL, Chan VCW, et al. Association between serrated polyps and the risk of synchronous advanced colorectal neoplasia in average-risk individuals. Aliment Pharmacol Amp Ther. 2015; 41(1):108–115.
84. Erichsen R, Baron JA, Hamilton-Dutoit SJ, et al. Increased risk of colorectal cancer development among patients with serrated polyps. Gastroenterology. 2016;150(4):895–902.
85. Melson J, Ma K, Arshad S, et al. Presence of small sessile serrated polyps increases rate of advanced neoplasia upon surveillance compared with isolated low-risk tubular adenomas. Gastrointest Endosc. 2016;84(2):307–314.
86. Lu FI, de W van N, Owen D, Tha SP, Turbin DA, Webber DL. Longitudinal outcome study of sessile serrated adenomas of the colorectum: an increased risk for subsequent right-sided colorectal carcinoma. Am J Surg Pathol. 2010;34(7):927–934.
87. Teriaky A, Driman DK, Chande N. Outcomes of a 5-year follow-up of patients with sessile serrated adenomas. Scand J Gastroenterol. 2012;47(2):178–183.
88. Macaron C, Vu HT, Lopez R, Pai RK, Burke CA. Risk of metachronous polyps in individuals with serrated polyps. Dis Colon Rectum. 2015;58(8):762–768.
89. IJspeert JEG, Rana SAQ, Atkinson NSS, et al. Clinical risk factors of colorectal cancer in patients with serrated polyposis syndrome: a multicentre cohort analysis. Gut. 2015;66(2):278–284.
90. Kahi CJ, Hewett DG, Norton DL, Eckert GJ, Rex DK. Prevalence and variable detection of proximal colon serrated polyps during screening colonoscopy. Clin Gastroenterol Hepatol. 2011;9(1):42–46.
91. de Wijkerslooth TR, Stoop EM, Bossuyt PM, et al. Differences in proximal serrated polyp detection among endoscopists are associated with variability in withdrawal time. Gastrointest Endosc. 2013; 77(4):617–623.
92. Parra-Blanco A, Nicolas-Perez D, Gimeno-Garcia A, et al. The timing of bowel preparation before colonoscopy determines the quality of cleansing, and is a significant factor contributing to the detection of flat lesions: a randomized study. World J Gastroenterol. 2006;12(38):6161–6166.
93. Clark BT, Laine L. High-quality bowel preparation is required for detection of sessile serrated polyps. Clin Gastroenterol Hepatol. 2016;14(8):1155–1162.
94. Lasisi F, Rex DK. Improving protection against proximal colon cancer by colonoscopy. Expert Rev Gastroenterol Hepatol. 2011;5(6): 745–754.
95. Waldock A, Ellis IO, Armitage NC, Turner DR, Hardcastle JD. Histopathological assessment of bleeding from polyps of the colon and rectum. J Clin Pathol. 1989;42(4):378–382.
96. Sobin LH. The histopathology of bleeding from polyps and carcinomas of the large intestine. Cancer. 1985;55(3):577–581.
97. Chang LC, Shun CT, Hsu WF, et al. Fecal immunochemical test detects sessile serrated adenomas and polyps with a low level of sensitivity. Clin Gastroenterol Hepatol. 2016. Epub 2016 Aug 4.
98. IJspeert JE, Nolthenius CJT, Kuipers EJ, et al. CT-colonography vs. colonoscopy for detection of high-risk sessile serrated polyps. Am J Gastroenterol. 2016;111(4):516–522.
99. Kahi CJ, Vemulapalli KC, Snover DC, Jawad KHA, Cummings OW, Rex DK. Findings in the distal colorectum are not associated with proximal advanced serrated lesions. Clin Gastroenterol Hepatol. 2015;13(2):345–351.
100. Imperiale TF, Ransohoff DF, Itzkowitz SH, et al. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med. 2014;370(14):1287–1297.
101. Redwood DG, Asay ED, Blake ID, et al. Stool DNA testing for screening detection of colorectal neoplasia in Alaska native people. Mayo Clin Proc. 2016;91(1):61–70.
102. Heigh RI, Yab TC, Taylor WR, et al. Detection of colorectal serrated polyps by stool DNA testing: comparison with fecal immunochemical testing for occult blood (FIT). PLoS One. 2014;9(1):e85659.
103. Lidgard GP, Domanico MJ, Bruinsma JJ, et al. Clinical performance of an automated stool DNA assay for detection of colorectal neoplasia. Clin Gastroenterol Hepatol. 2013;11(10):1313–1318.
104. Jin YM, Li BJ, Qu B, Du YJ. BRAF, K-ras and BAT26 mutations in colorectal polyps and stool. World J Gastroenterol. 2006;12(32): 5148–5152.
105. Kiesslich R, von Bergh M, Hahn M, Hermann G, Jung M. Chromoendoscopy with indigocarmine improves the detection of adenomatous and nonadenomatous lesions in the colon. Endoscopy. 2001;33(12):1001–1006.
106. Brooker JC, Saunders BP, Shah SG, et al. Total colonic dye-spray increases the detection of diminutive adenomas during routine colonoscopy: a randomized controlled trial. Gastrointest Endosc. 2002;56(3):333–338.
107. Lapalus MG, Helbert T, Napoleon B, et al. Does chromoendoscopy with structure enhancement improve the colonoscopic adenoma detection rate? Endoscopy. 2006;38(5):444–448.
108. Kahi CJ, Anderson JC, Waxman I, et al. High-definition chromocolonoscopy vs. high-definition white light colonoscopy for average-risk colorectal cancer screening. Am J Gastroenterol. 2010; 105(6):1301–1317.
109. Rex DK. Narrow-band imaging without optical magnification for histologic analysis of colorectal polyps. Gastroenterology. 2009; 136(4):1174–1181.
110. Kanao H, Tanaka S, Oka S, Hirata M, Yoshida S, Chayama K. Narrowband imaging magnification predicts the histology and invasion depth of colorectal tumors. Gastrointest Endosc. 2009;69(3 Pt 2):631–636.
111. East JE, Suzuki N, Bassett P, et al. Narrow band imaging with magnification for the characterization of small and diminutive colonic polyps: pit pattern and vascular pattern intensity. Endoscopy. 2008;40(10):811–817.
112. Hewett DG, Kaltenbach T, Sano Y, et al. Validation of a simple classification system for endoscopic diagnosis of small colorectal polyps using narrow-band imaging. Gastroenterology. 2012;143(3):599–607.
113. IJspeert JEG, Bastiaansen BAJ, Leerdam ME van, et al. Development and validation of the WASP classification system for optical diagnosis of adenomas, hyperplastic polyps and sessile serrated adenomas/ polyps. Gut. 2016;65(6):963–970.
114. Parikh ND, Chaptini L, Njei B, Laine L. Diagnosis of sessile serrated adenomas/polyps with image-enhanced endoscopy: a systematic review and meta-analysis. Endoscopy. 2016;48(8):731–739.
115. Gralnek IM, Siersema PD, Halpern Z, et al. Standard forward-viewing colonoscopy versus full-spectrum endoscopy: an international, multicentre, randomised, tandem colonoscopy trial. Lancet Oncol. 2014;15(3):353–360.
116. Waye JD, Heigh RI, Fleischer DE, et al. A retrograde-viewing device improves detection of adenomas in the colon: a prospective efficacy evaluation (with videos). Gastrointest Endosc. 2010;71(3):551–556.
117. Leufkens AM, DeMarco DC, Rastogi A, et al. Effect of a retrogradeviewing device on adenoma detection rate during colonoscopy: the TERRACE study. Gastrointest Endosc. 2011;73(3):480–489.
118. Pohl H, Srivastava A, Bensen SP, et al. Incomplete polyp resection during colonoscopy-results of the complete adenoma resection (CARE) study. Gastroenterology. 2013;144(1):74–80.
119. Farrar WD, Sawhney MS, Nelson DB, Lederle FA, Bond JH. Colorectal cancers found after a complete colonoscopy. Clin Gastroenterol Hepatol. 2006;4(10):1259–1264.
120. Uno Y, Obara K, Zheng P, et al. Cold snare excision is a safe method for diminutive colorectal polyps. Tohoku J Exp Med. 1997;183(4):243–249.
121. Tappero G, Gaia E, Giuli PD, Martini S, Gubetta L, Emanuelli G. Cold snare excision of small colorectal polyps. Gastrointest Endosc. 1992;38(3):310–313.
122. Holt BA, Jayasekeran V, Sonson R, Bourke MJ. Topical submucosal chromoendoscopy defines the level of resection in colonic EMR and may improve procedural safety (with video). Gastrointest Endosc. 2013;77(6):949–953.
123. Dolz-Abadia C, Vilella-Martorell A. Submucosal chromoendoscopy. A technique that highlights epithelia and differentiates histological components, and renders colon polypectomy easier and safer. Rev Esp Enferm Dig. 2015;107(7):430–435.
124. Farris AB, Misdraji J, Srivastava A, et al. Sessile serrated adenoma: challenging discrimination from other serrated colonic polyps. Am J Surg Pathol. 2008;32(1):30–35.
125. Schachschal G, Sehner S, Choschzick M, et al. Impact of reassessment of colonic hyperplastic polyps by expert GI pathologists. Int J Colorectal Dis. 2016;31(3):675–683.
126. Gill P, Wang LM, Bailey A, East JE, Leedham S, Chetty R. Reporting trends of right-sided hyperplastic and sessile serrated polyps in a large teaching hospital over a 4-year period (2009-2012). J Clin Pathol. 2013;66(8):655–658.
127. Lieberman DA, Rex DK, Winawer SJ, Giardiello FM, Johnson DA, Levin TR. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US multi-society task force on colorectal cancer. Gastroenterology. 2012;143(3): 844–857.
128. Atkin WS, Valori R, Kuipers EJ, et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition – colonoscopic surveillance following adenoma removal. Endoscopy. 2012;44(Suppl 3):SE151–SE163.
129. Sanaka MR, Gohel T, Podugu A, et al. Adenoma and sessile serrated polyp detection rates: variation by patient sex and colonic segment but not specialty of the endoscopist. Dis Colon Rectum. 2014;57(9): 1113–1119.
130. Raju GS, Vadyala V, Slack R, et al. Adenoma detection in patients undergoing a comprehensive colonoscopy screening. Cancer Med. 2013;2(3):391–402.
131. Sweetser S, Baron TH. Optimizing resection of sessile serrated polyps. Endoscopy. 2014;(46 Suppl 1) UCTN:E231–0034–1365379. Epub 2014 May 7.
132. Raad D, Tripathi P, Cooper G, Falck-Ytter Y. Role of the cold biopsy technique in diminutive and small colonic polyp removal: a systematic review and meta-analysis. Gastrointest Endosc. 2016;83(3):508–515.
133. Yen AW, Leung JW, Leung FW. A novel method with significant impact on adenoma detection: combined water-exchange and cap-assisted colonoscopy. Gastrointest Endosc. 2013;77(6):944–948.